慕尼黑获得了250万欧元的创新哮喘治疗！

慕尼黑获得了250万欧元的创新哮喘治疗！

München, Deutschland - 慕尼黑是医疗创新的热点，欢迎一个开创性的哮喘治疗项目！这家年轻的公司RNHALE从慕尼黑（LMU）的著名路德维希·马克西米利人大学（Ludwig Maximilians University）出现，从欧洲创新委员会（EIC）获得了250万欧元的赠款。 This valuable support is intended to develop a new medication based on RNA therapeutic agents to inhale that could help asthma patients, such as merkel.cup.uni-muenchen.de . In the future, this will not only be better treated, but also research in the呼吸道疾病区域。